Quince Therapeutics
QNCX
#9491
Rank
โ‚น4.44 B
Marketcap
โ‚น100.69
Share price
4.89%
Change (1 day)
13.98%
Change (1 year)

EPS for Quince Therapeutics (QNCX)

EPS in 2023 (TTM): -โ‚น68.09

According to Quince Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น70.83. In 2022 the company made an earnings per share (EPS) of -โ‚น134.83 an increase over its 2021 EPS that were of -โ‚น258.56.

EPS history for Quince Therapeutics from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น68.09-49.5%
2022-โ‚น134.83-47.85%
2021-โ‚น258.5615.21%
2020-โ‚น224.4362.51%
2019-โ‚น138.10179.56%
2018-โ‚น49.40

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-โ‚น186.03 162.65%๐Ÿ‡บ๐Ÿ‡ธ USA